Home | Links | Contact Us | More About Intellectual Property | Bookmark
Search patents:
Home Gene Therapy Poly-ethylene-glycol-derivatives-with-proximal-reactive-groups

 Episomal vector systems and related methods
The present invention provides papilloma virus episomal vector systems and methods for papilloma ...


 Method for treating Parkinson's disease employing an ATP-sensitive potassium channel blocker
What is claimed is: 1. A method for treating Parkinson's disease, which comprises administering ...


 Method of treatment of parkinson's disease
We claim: 1. A method of treatment of Parkinson's disease in a patient in need of such treatment, ...


 4-aminoethoxy indolone derivatives
What is claimed is: 1. A compound of the formula I: ##STR5## in which: Y is hydrogen, halogen or ...


 Genetically engineered cells that produce produce L. Dopa
In one aspect, the present invention provides a process of increasing the production of dopamine in ...


 C. elegans deletion mutants
What is claimed is: 1. A nematode having null mutations in hop-1 and sel-12, said nematode having a ...


 Feline hepatocyte growth factor
The invention claimed is: 1. An isolated DNA or RNA encoding a protein having an amino acid ...


 ppRB.sup.110 -phosphoprotein the retinoblastoma susceptibility gene product
OF FIGURES FIG. 1 is the chromatogram illustrating the identification of RB proteins by ...


 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
It has now been discovered that tumor formation in a patient can be treated or prevented by ...


 Mutants of the RB and P53 genes
OF THE INVENTION Definitions The term "functional expression of the gene" meant to include the ...


 Poly(ethylene glycol) derivatives with proximal reactive groups

Details
Inventors: Harris, J. Milton; Kozlowski, Antoni;
Assignee: Shearwater Corporation (Huntsville, AL)
Primary Examiner: Nutter; Nathan M.
Assistant Examiner:
Attorney, Agent or Firm: Alston & Bird LLP

An activated, substantially water soluble poly(ethylene glycol) is provided having of a linear or branched poly(ethylene glycol) backbone and at least one terminus linked to the backbone through a hydrolytically stable linkage, wherein the terminus is branched and has proximal reactive groups. The free reactive groups are capable of reacting with active moieties in a biologically active agent such as a protein or peptide thus forming conjugates between the activated poly(ethylene glycol) and the biologically active agent.

DETAILED DESCRIPTION OF THE INVENTION The terms "group," "functional group," "moiety," "active moiety," "reactive site," reactive group" and "reactive moiety" are used in the art and herein to refer to distinct, definable portions or units of a molecule.
The terms are somewhat synonymous in the chemical arts and are used herein to indicate that the portions of molecules that perform some function or activity and are reactive with other portions of molecules.
The term "linkage" is used herein to refer to groups or bonds that normally are formed as the result of a chemical reaction and typically are covalent linkages.
Hydrolytically stable linkages means that the linkages are substantially stable in water and do not react with water at useful pHs, e.
g.
, under physiological conditions for an extended period of time, preferably indefinitely.
The term "biologically active agent" when used herein means any substance which can affect any physical or biochemical properties of a biological organism, including but not limited to viruses, bacteria, fungi, plants, animals, and humans.
In particular, as used herein, biologically active agent includes any substance intended for the diagnosis, cure, mitigation, treatment, or prevention of disease in humans or other animals, or to otherwise enhance physical or mental well being of humans or animals.
Examples of biologically active agents include, but are not limited to, organic and inorganic compounds, proteins, peptides, lipids, polysaccharides, nucleotides, DNAs, RNAs, other polymers, and derivatives thereof.
Examples of biologically active agents include antibiotics, fungicides, anti-viral agents, anti-inflammatory agents, anti-tumor agents, cardiovascular agents, anti-anxiety agents, hormones, growth factors, steroidal agents, and the like.
Other examples include, microorganisms such as bacteria and yeast cells, viral particles, plant or animal or human cells, and the like.
The polymer backbone is a water soluble substantially non-immunogenic polymer, and is preferably poly(ethylene glycol) (PEG)



Related patents
  Devices for cloaking transplanted cells
A variety of devices can be used to contain or cloak a source of a therapeutic substance, often cells, which source provides the substance to a host or recipient subject....
  Terminally-branched polymeric linkers and polymeric conjugates containing the same
In one aspect of the invention, compounds of Formula (I) are provided: ##STR6## wherein: J is ##STR7## E.sub.1-4 are independently selected from the group consisting of ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered composition comprising rectally administering to a patient a ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A method of enhancing the rate of absorption of a rectally administered composition comprising a therapeutically effective dosage amount of an ...
  Rectally absorbable form of L-dopa
What is claimed is: 1. A pharmaceutical composition for enhancing rectal absorption of L-dopa by administering a formulation comprising a therapeutically effective ...
  Method to treat Parkinsons disease
I claim: 1. The method of treatment of Parkinson's disease and related neurological syndromes which consists of administering by the oral or sublingual route to a ...
  Method of using cytoprotective alcohols to treat neural disease and neural injury
The present invention is grounded in the surprising discovery that hexacosanol and analogues and homologs thereof, including saturated and unsaturated straight chain ...
  Methods of treating Parkinson's disease using melanin
OF THE INVENTION One aspect of the present invention relates to the treatment of a mammal having a disease of a tissue which exhibits a melanin deficiency by the ...
  Method of treating memory disorders using R-enantiomers of N-propargyl-aminoindan compounds
OF THE INVENTION The present invention thus provides as a novel compound the R(+)-enantiomer of N-propargyl-1-aminoindan [R(+)PAI] of the formula (I): ##STR1## and ...
  L-DOPA ethyl ester to treat Parkinson's disease
OF THE INVENTION This invention provides a composition which comprises a pharmaceutically acceptable carrier and an active ingredient, such active ingredient comprising ...

0.004

Archive: All patents - Links

Copyright (c)2006 Eipa-patents.org - All rights reserved